AMAERO LTD — Director's Dealing 2024

Jun 23, 2024

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Amaero International Limited ABN 82 633 541 634

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Bob Latta
Date of last notice	27 December 2023

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct & Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	1) Pegasus Growth Capital Fund I Mr Latta is a partner of Pegasus Growth Capital and holds a minority interest in the shares held by Pegasus Growth Capital Fund in Amaero International Limited. Mr Latta and his spouse have an indirect beneficial interest in approximately 6.3% of Pegasus’ total shares; and 2) Robert Latta
Date of change	20 June 2024

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held prior to change	1) 188,524,968 Fully Paid Ordinary Shares (indirect beneficial interest of 6.3% of these shares held by Pegasus); 2) 18,673,464 Options Expiring 1 August 2025, ex. $0.42; 3) 25,000,000 Options, Expiring 28 December 2026 ex. $0.24; 4) 126,178,039 Listed Options expiring 2 December 2025 ex. $0.18; 5) 500,000 Options Expiring 31 October 2033, Ex. $0.190; and 6) 500,000 Options Expiring 08 November 2033, Ex. $0.248.
Class	Ordinary Shares
Number acquired	3,200,000 Ordinary shares acquired by Pegasus
Number disposed	Nil
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	$0.35 per share
No. of securities held after change	1) 191,724,968 Fully Paid Ordinary Shares (indirect beneficial interest of 6.3% of these shares held by Pegasus); 2) 18,673,464 Options Expiring 1 August 2025, ex. $0.42; 3) 25,000,000 Options, Expiring 28December 2026 ex. $0.24; 4) 126,178,039 Listed Options expiring 2 December 2025 ex. $0.18; 5) 500,000 Options Expiring 31 October 2033, Ex. $0.190 (held directly); and 6) 500,000 Options Expiring 08 November 2033, Ex. $0.248 (held directly).
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	Off Market Trade.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Name of registered holder (if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	N/A
Interest after change	N/A

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3